Cargando…

Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity

The combination of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, with an acetylcholinesterase inhibitor (AChEI) is the current standard of care in Alzheimer's disease (AD). Galantamine, an AChEI currently marketed for the treatment of AD, exerts memory-enhancing and neuroprotec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopes, João P, Tarozzo, Glauco, Reggiani, Angelo, Piomelli, Daniele, Cavalli, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607148/ https://www.ncbi.nlm.nih.gov/pubmed/23532860 http://dx.doi.org/10.1002/brb3.118

Ejemplares similares

Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
por: Capurro, Valeria, et al.
Publicado: (2013)

In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
por: Reggiani, Angelo M., et al.
Publicado: (2016)

Neuroprotective Effects of Daphnetin against NMDA Receptor-Mediated Excitotoxicity
por: Yang, Le, et al.
Publicado: (2014)

Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity
por: Saliba, Soraya Wilke, et al.
Publicado: (2019)

The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity
por: Yang, Xiaorong, et al.
Publicado: (2017)

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
por: Zarra, Julio, et al.
Publicado: (2010)

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
por: Koola, Maju Mathew
Publicado: (2016)

Galantamine-memantine combination effective in dementia: Translate to dementia praecox?
por: Koola, Maju Mathew, et al.
Publicado: (2018)

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
por: Peters, Oliver, et al.
Publicado: (2015)

Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
por: Li, Victor, et al.
Publicado: (2016)

Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
por: Koola, Maju Mathew, et al.
Publicado: (2018)

Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult
por: Ferrer-Acosta, Yancy, et al.
Publicado: (2022)

Molecular mechanisms of NMDA excitotoxicity in the retina
por: Dvoriantchikova, Galina, et al.
Publicado: (2023)

Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity
por: Black, Stefanie A. G., et al.
Publicado: (2014)

Melanopsin(+)RGCs Are fully Resistant to NMDA-Induced Excitotoxicity
por: Vidal-Villegas, Beatriz, et al.
Publicado: (2019)

Neuroprotection by MKK7 inhibition in excitotoxicity
por: Vercelli, Alessandro, et al.
Publicado: (2015)

Neuroprotective potential of Marsilea quadrifolia Linn against monosodium glutamate-induced excitotoxicity in rats
por: Subramanian, Arunkumar, et al.
Publicado: (2023)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
por: Kano, Osamu, et al.
Publicado: (2013)

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
por: Li, Dan-Dan, et al.
Publicado: (2019)

Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotection
por: Díaz-Guerra, Margarita
Publicado: (2020)

Endocytosis of GluN2B-containing NMDA receptor mediates NMDA-induced excitotoxicity
por: Wu, Yu, et al.
Publicado: (2017)

Prion protein attenuates excitotoxicity by inhibiting NMDA receptors
por: Khosravani, Houman, et al.
Publicado: (2008)

Prion protein attenuates excitotoxicity by inhibiting NMDA receptors
por: Khosravani, Houman, et al.
Publicado: (2009)

The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats
por: RALLI, M., et al.
Publicado: (2014)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Neuroprotective Potential of Biphalin, Multireceptor Opioid Peptide, Against Excitotoxic Injury in Hippocampal Organotypic Culture
por: Kawalec, Maria, et al.
Publicado: (2011)

Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists
por: Martins, Antonio H., et al.
Publicado: (2012)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2015)

Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
por: Alsikhan, Rawan S., et al.
Publicado: (2023)

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation
por: Yang, Qianwen, et al.
Publicado: (2019)

Neuroprotective function for ramified microglia in hippocampal excitotoxicity
por: Vinet, Jonathan, et al.
Publicado: (2012)

Design, Synthesis, and Biological Evaluation of Novel Tomentosin Derivatives in NMDA-Induced Excitotoxicity
por: Zaki, Mohamed, et al.
Publicado: (2022)

NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
por: Zhou, X, et al.
Publicado: (2013)

Long-Term Dynamic Changes of NMDA Receptors Following an Excitotoxic Challenge
por: Granzotto, Alberto, et al.
Publicado: (2022)

Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2016)

Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
por: Almasieh, M, et al.
Publicado: (2010)

Neuroprotective Potential of L-Glutamate Transporters in Human Induced Pluripotent Stem Cell-Derived Neural Cells against Excitotoxicity
por: Takahashi, Kanako, et al.
Publicado: (2023)

Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector
por: Peluffo, Hugo, et al.
Publicado: (2006)

NMDA Receptor-Mediated Neuroprotective Effect of the Scutellaria baicalensis Georgi Extract on the Excitotoxic Neuronal Cell Death in Primary Rat Cortical Cell Cultures
por: Yang, Jinsong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i2081md5dk801l5ljp6v7j1oh1